The insider trading reports reveal that during the month of December, Sopharma sold 5 481 414 shares (79.7% of the traded volume) at an average price of BGN 2.75/share. Total treasury stock after the transactions stood at 13 624 541 or 2.53% of issued shares. Ognyan Donev, who is an Executive Director, Chairman of the BoD and largest beneficiary owner of Sopharma, has net purchases of 7 573 Sopharma’s shares directly and net purchases of 161 027 shares through one of his companies. Our calculations show that as of the end of the year, Ognyan Donev is 0.004% shy of 50% stake.